Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells.
In the present study, 10 clinical isolates of dengue virus were selected according to their susceptibility to the inhibitory effect of nitric oxide radical, NO. Five of them are nitric oxide-susceptible viruses while the other five are nitric oxide-resistant viruses. These isolates were investigated to identify genetic factors that are responsible for the different phenotypes. Due to the evidence showing that NO suppresses DENV RNA polymerase activity, we, therefore, hypothesized that the RdRp domain of NS5 may responsible for NO inhibition. To answer this question, sequences of NS5 gene of NO-susceptible viruses and NO-resistant viruses were compared. We found that these two groups of viruses contain different amino acid sequence at position 621 to 646 in the active site of NS5. These data suggested that response to the inhibitory effect of nitric oxide radical may, at least in part, be regulated by NS5. The effect of these two different phenotypes of viruses on host cells was studied using cDNA array screening. The cDNA array analysis demonstrated that the nitric oxide-resistant group had a stronger influence on host cells since it induced changes in the expression of a greater number of genes than did the nitric oxide-susceptible group, 97 genes versus 71 genes, respectively. The NO-resistant virus also stimulated cytokines known to be virulent factors, such as IL 6, IL 8, RANTES, and the inflammatory factors. In conclusion, our data demonstrated that dengue viruses isolated from patients show genotypic and phenotypic differences which may correlate with virulence.
Ubol
Sukathida
S
Department of Microbiology, Faculty of Science, Mahidol University, 272 Rama 6 Rd., Ratchatewee, Bangkok 10400, Thailand. scsul@mahidol.ac.th
Chareonsirisuthigul
Takol
T
Kasisith
Jitra
J
Klungthong
Chonticha
C
D000595:Amino Acid Sequence; D002460:Cell Line; D016207:Cytokines / Q000096:biosynthesis / Q000235:genetics; D003715:Dengue / Q000821:virology*; D003716:Dengue Virus / Q000187:drug effects* / Q000472:pathogenicity / Q000502:physiology*; D016166:Free Radical Scavengers / Q000494:pharmacology*; D020869:Gene Expression Profiling; D006801:Humans; D008826:Microbial Sensitivity Tests; D008969:Molecular Sequence Data; D009000:Monocytes / Q000276:immunology / Q000378:metabolism / Q000821:virology; D009569:Nitric Oxide / Q000096:biosynthesis / Q000494:pharmacology*; D052247:Nitric Oxide Synthase Type II / Q000037:antagonists & inhibitors / Q000494:pharmacology; D012324:RNA-Dependent RNA Polymerase / Q000235:genetics*; D016415:Sequence Alignment; D017361:Viral Nonstructural Proteins / Q000737:chemistry / Q000235:genetics; D014779:Virus Replication
D016207:Cytokines; D016166:Free Radical Scavengers; C096041:NS5 protein, flavivirus; D017361:Viral Nonstructural Proteins; D009569:Nitric Oxide; D052247:Nitric Oxide Synthase Type II; D012324:RNA-Dependent RNA Polymerase